−0.585CAD
−11.57 MCAD
24.76 M
About MYDECINE INNOVATIONS GROUP INC.
Sector
CEO
David Joshua Bartch
Headquarters
Vancouver
Website
Employees (FY)
3
Founded
2013
FIGI
BBG0086KMT58
Mydecine Innovations Group, Inc. is a biotechnology company. It engages in the business of creating the latest novel drugs and therapies to treat mental health conditions like nicotine addiction and post-traumatic stress disorder. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MYCO is 0.020 CAD — it has increased by 33.33% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange MYDECINE INNOVATIONS GROUP INC. stocks are traded under the ticker MYCO.
MYDECINE INNOVATIONS GROUP INC. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
MYCO stock is 25.00% volatile and has beta coefficient of 0.84. Check out the list of the most volatile stocks — is MYDECINE INNOVATIONS GROUP INC. there?
MYCO earnings for the last quarter are −0.35 CAD per share, whereas the estimation was −1.00 CAD resulting in a 65.00% surprise. The estimated earnings for the next quarter are −1.00 CAD per share. See more details about MYDECINE INNOVATIONS GROUP INC. earnings.
MYDECINE INNOVATIONS GROUP INC. revenue for the last quarter amounts to 73.00 CAD despite the estimated figure of 0 CAD. In the next quarter revenue is expected to reach 300.00 K CAD.
Yes, you can track MYDECINE INNOVATIONS GROUP INC. financials in yearly and quarterly reports right on TradingView.
MYCO stock hasn't changed in a week, the month change is a 33.33% rise, over the last year MYDECINE INNOVATIONS GROUP INC. has showed a 97.26% decrease.
MYCO net income for the last quarter is −1.18 M CAD, while the quarter before that showed −3.18 M CAD of net income which accounts for 62.81% change. Track more MYDECINE INNOVATIONS GROUP INC. financial stats to get the full picture.
No, MYCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MYCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MYDECINE INNOVATIONS GROUP INC. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 3.00 employees. See our rating of the largest employees — is MYDECINE INNOVATIONS GROUP INC. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MYDECINE INNOVATIONS GROUP INC. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MYDECINE INNOVATIONS GROUP INC. stock shows the sell signal. See more of MYDECINE INNOVATIONS GROUP INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.